FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...